[1]
A. Borowiec, A. Właszczuk, E. Olakowska, and J. Lewin-Kowalik, “TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients”, Medicine and Pharmacy Reports, Jun. 2022.